Psychiatry Related News
ALTO-100 Trial: Using Cognitive Biomarkers to Personalize Depression Treatment
Psychiatry | 16 July 2024
New Horizons in Schizophrenia Treatment: ALTO-101 Targets Cognitive Dysfunction
Psychiatry | 25 June 2024
Novel Study Suggests Wegovy May Reduce Alcohol Use Disorder Symptoms
Psychiatry | 28 November 2023
Stanford Study Underline the Power of Expectations in Depression Treatment
Psychiatry | 22 October 2023
Subscribe for the latest news and events
Most Popular
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
Novartis and Legend Biotech Strike $1 Billion Deal on CAR-T Therapy for Lung Cancer
Overcoming Challenges and Expanding Access to CAR T-Cell Therapy
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
A New Horizon in Rare Disease Treatment: FDA Approves Wainua for ATTR-PN